​The symposium is led by the EU-funded Innovative Training Network "Innovation in modelling Placenta for Maternal and Fetal Health" (iPLACENTA) in collaboration with the Australian and New Zealand Placental Research Association (ANZPRA).

In addition to talks from guest speakers, its aim is to give early-career researchers an opportunity to showcase their work and allow discussions and networking with members of the two groups.

The symposium is free but registration is required.
​
Register on Eventbrite

Poster sessions: May 5th 2021
London: 9-10am, Paris: 10-11am, Melbourne: 6-7pm, Auckland: 8-9pm

There will be three dedicated poster sessions on the day before the symposium. Posters will be accessible to registered attendees between May 4th and 8th.​

Poster sessions:
Imaging/Modelling and new technologies in MFH
Pathology and Maternal Health
Proteo-genomics of the placenta

​
Symposium: May 6th 2021
London: 8am-1pm, Paris: 9am-2pm, Melbourne: 5-10pm, Auckland: 7pm-12am

Section 1: Next generation models and diagnostics of Preeclampsia and IUGR

• Prof Carlos Salomon, University of Queensland: Placental extracellular vesicles across gestation and their potential as early biomarkers of preeclampsia
• Prof Jo James, University of Auckland: Knowledge is power: Linking anatomical and functional changes to improve the prediction and detection of fetal growth restriction
• Prof Patricia Maguire, University College Dublin: AI_PREMie: a novel risk stratification tool for preeclamptic toxaemia
• Natalia Gebara, University of Turin: Characterization and function of amniotic fluid derived extracellular vesicles in pre-eclampsia
• Samprikta Manna, University College Cork: Investigation of premature cellular senescence in Pre-eclampsia and Intrauterine Growth restriction
• Jessica O'Callaghan, Queensland University of Technology: Sex-specific methylation and expression differences in the placenta of infants born small for gestational age
• Gwenaelle Rabussier, Mimetas BV: Development of a 3D microphysiological placenta in-vitro model as a tool for drug transport studies

​Section 2: Adverse pregnancies, a stress test for further maternal complications

• Prof Susan Ozanne, University of Cambridge: Exploring the consequences of obesity during pregnancy for mother and child: a window of opportunity
• Prof Asma Khalil, St George's, University of London: Impact of Covid-19 on pregnancy
• Dr Peter Barrett, University College Cork: Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study
• Dr Rachael Crew, University of Western Australia: Characterising the structural, haemodynamic and molecular phenotype of the feto-placental vascular network in a rat model of fetal growth restriction
• Antonia Hufnagel, University of Cambridge: Diet-induced maternal obesity leads to reduced uterine artery compliance and fetal growth-restriction in a murine model

Key speakers and abstracts
​Full programme
​

---

Organising committee:

Dr Colin Murdoch, University of Dundee
Mirren Augustin, University of Dundee
Prof Benedetta Bussolati, University of Torino
Dr Cathal McCarthy, University College Cork
in collaboration with Prof Jo James, University of Auckland

Early-stage researcher organising team:

Agathe Lermant, Camilla Soragni, Camino Ruano, Carolina Di Fabrizio, Clara Apicella, Gabriela Loscalzo, Gwenaelle Rabussier, Ignacio Valenzuela, Jana-Ch. Hegenbarth, Julia Scheel, Lukas Markwalder, Natalia Gebara, Samprikta Manna, Veronica Giorgione, Yolanda Correia